Back to Journals » ClinicoEconomics and Outcomes Research » Volume 11

Cost-effectiveness analysis of baricitinib versus adalimumab for the treatment of moderate-to-severe rheumatoid arthritis in Spain

Total article views   HTML views PDF downloads Totals
15,346 Dovepress* 13,983+ 1,795 15,778
PubMed Central* 1,363 479 1,842
Totals 15,346 2,274 17,620
*Since 6 June 2019

View citations on PubMed Central and Google Scholar